Review Articles Concerning Pulmonary Vascular Disease

MicroRNA Signatures in Cardiovascular Diseases: A Systematic Literature Review

Hariballav Mahapatra, Pankaj Banotra, Anand Sekar G, Jignesh Sharma, Sharat Vishwanath K, Dinesh TripathiSevayan Diabetes Centre. Sri Jayadeva Institute of Cardiovascular Sciences. Aarupadai Veedu Medical College and Vinayaka Missions Research Foundation. Mansarovar Medical College. Bhopal Memorial Hospital and Research Centre of Bhopal Nursing College. Subharti Medical College.India CureusCureus 2026; 18: DOI: 10.7759/cureus.110938 AbstractCardiovascular diseases remain the […]

MicroRNA Signatures in Cardiovascular Diseases: A Systematic Literature Review Read More »

Hemodynamic phenotyping of bronchopulmonary dysplasia: from transitional circulation to precision cardiopulmonary care

Gabriela S. Trindade, Bianca C. Benincasa, Rita C. Silveira, Renato S. ProcianoyHospital de Clínicas de Porto Alegre and Universidade Federal do Rio Grande do Sul.Brazil Frontiers in PediatricsFront Pediatr 2026; 14: DOI: 10.3389/fped.2026.1877119 AbstractObjectives: Bronchopulmonary dysplasia (BPD) remains one of the most important complications of extreme prematurity and a leading cause of long-term respiratory, cardiovascular, and neurodevelopmental

Hemodynamic phenotyping of bronchopulmonary dysplasia: from transitional circulation to precision cardiopulmonary care Read More »

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis

Yuichi Tamura, Kenya Kusunose, Yugo Yamashita, Teiji Akagi, Masanori Atsukawa, Yoshihiro Fukumoto, Ayumi Goda, Shinya Goto, Masaru Hatano, Masataka Ikeda, Keiichi Ishida, Masaharu Kataoka, Masataka Kuwana, Hiromi Matsubara, Makoto Mo, Tetsutaro Nagaoka, Takeshi Ogo, Yoshinori Okada, Seiichiro Sakao, Hirofumi Sawada, Toshiro Shinke, Nobuhiro Tanabe, Norikazu Yamada, Hiroyuki Yamagishi, Shingo Yano, Kohtaro Abe, Shiro Adachi, Kazuya

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis Read More »

Long-Term Complications of Sickle Cell Disease

Luisanna M. Sánchez, Ajibike Lapite, Alicia Chang, Titilope A. FasipeIndiana Hemophilia and Thrombosis Center. Baylor College of Medicine and exas Children’s Hospital. University of Texas at Austin and Dell Children’s Hospital. United States Pediatrics in ReviewPediatr Rev 2026; 47: 394-403DOI: 10.1542/pir.2024-006446 AbstractSCD is a prevalent genetic disorder marked by chronic complications that impact quality of life

Long-Term Complications of Sickle Cell Disease Read More »

Phenotype-based screening algorithm for chronic pulmonary hypertension in preterm infants with bronchopulmonary dysplasia

Sarah E. Diamond, Amy H. Stanford, Adrianne R. Bischoff, Patrick J. McNamara, Philip T. LevyUniversity of Arkansas for Medical Sciences and Arkansas Children’s Hospital. University of Iowa. Boston Children’s Hospital and Harvard Medical School. United States Journal of PerinatologyJ Perinatol 2026; DOI: 10.1038/s41372-026-02776-w AbstractChronic pulmonary hypertension (cPH) associated with bronchopulmonary dysplasia (BPD) remains a major contributor

Phenotype-based screening algorithm for chronic pulmonary hypertension in preterm infants with bronchopulmonary dysplasia Read More »

L-Citrulline: Novel Pharmacotherapy to Improve Outcomes in Infants and Children at Risk of Systemic or Pulmonary Vascular Disease

Candice D. Fike, Frederick E. Barr, Judy L. AschnerUniversity of Utah Health. Diversified Search Group. Hackensack Meridian School of Medicine.United States PharmaceuticalsPharmaceuticals 2026; 19: DOI: 10.3390/ph19060896 AbstractInfants and children suffering from a variety of heart, lung, and blood disorders are known to be at risk of developing systemic or pulmonary vascular disease. Despite progress made in

L-Citrulline: Novel Pharmacotherapy to Improve Outcomes in Infants and Children at Risk of Systemic or Pulmonary Vascular Disease Read More »

L-Citrulline in Maternal-Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications

Ana Collins-Smith, Sangeeta Jain, Sunil JainUniversity of Texas Medical Branch at Galveston.United States NutrientsNutrients 2026; 18: DOI: 10.3390/nu18121923 AbstractL-citrulline is a non-protein amino acid with critical roles in perinatal and neonatal physiology through the intestinal-renal arginine-citrulline axis and nitric oxide (NO) production. During pregnancy, L-citrulline supports placental angiogenesis, vascular adaptation, and fetal growth through augmentation of

L-Citrulline in Maternal-Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications Read More »

Congenital chylothorax in infants: An updated scoping review

A. Alghobaishi, S. I. Albraim, H. I. Albraim, N. S. Gubari, S. Khan, H. I. Thalib, S. AlaghaKing Fahad Armed Forces Hospital. Saudi German Hospital. MyClinic. Batterjee Medical College. Saudi Arabia African Journal of Thoracic and Critical Care MedicineAfr J Thorac Crit Care Med 2026; 32: DOI: 10.7196/AJTCCM.2025.v32i1.2701 AbstractBackground: Chylothorax is a medical condition characterised by the

Congenital chylothorax in infants: An updated scoping review Read More »

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan

Taylor P. Saley, Natalie Villafranco, Megan Griffiths, Kara N. GossUniversity of Texas at Austin Dell Medical School. Baylor College of Medicine and Texas Children’s Hospital. University of Texas Southwestern Medical Center. United States Paediatric Respiratory ReviewsPaediatr Respir Rev 2026; DOI: 10.1016/j.prrv.2026.05.006 AbstractBronchopulmonary dysplasia is a frequent complication of preterm birth and is often associated with the

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan Read More »

Recent Advances in Pulmonary Hypertension Management

Sarah P. Cohen Alexandria L. Miller, Saurabh Rajpal, Scott H. VisovattiOhio State University School of Medicine and Nationwide Children’s Hospital. United States Heart Failure ClinicsHeart Fail Clin 2026; 22: 371-385DOI: 10.1016/j.hfc.2026.02.011 AbstractSignificant progress has been made in the management of pulmonary hypertension (PH), and especially pulmonary arterial hypertnesion (PAH), over the last 3 decades. Recent advances

Recent Advances in Pulmonary Hypertension Management Read More »

Scroll to Top